China’s revised regulation on human genome editing: the good news and the bad news
"Well-defined, carefully crafted regulatory exceptions are often abused and exploited by commercial actors that engage in activities falling outside such narrow exceptions. For financial gain, such entities try to evade regulators and determine what they are able to get away with without suffering significant consequences." (Leigh Turner)
